You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sodium Glucose Co Transporter 2 inhibitors

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Transplant Recipients Trial in Toronto (Dapagliflozin 10 MG, Semaglutide, 1.0 mg/mL)

Not yet recruiting
  • Kidney Transplant Recipients
  • Dapagliflozin 10 MG
  • Semaglutide, 1.0 mg/mL
  • Toronto, Ontario, Canada
    Toronto General Hospital
Jul 6, 2023

Heart Failure Trial in Denmark (Digital letter)

Recruiting
  • Heart Failure
  • Digital letter
  • Copenhagen, Denmark
  • +4 more
Jun 5, 2023

Blood Pressure, Salt; Excess, Diabete Type 2 Trial in Pisa (Hypersodic/Hyposodic diet)

Recruiting
  • Blood Pressure
  • +2 more
  • Hypersodic/Hyposodic diet
  • Pisa, PI, Italy
    Azienda Ospedaliero-Universitaria Pisana
Aug 23, 2023

Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (Dapagliflozin, BIOSENSE meters)

Completed
Has Results
  • Pancreas Cancer
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 20, 2022

Heart Failure, Reduced Ejection Fraction Heart Failure Trial in Damanhur (Empagliflozin 10 MG, Dapagliflozin 10 MG)

Recruiting
  • Heart Failure
  • Reduced Ejection Fraction Heart Failure
  • Empagliflozin 10 MG
  • Dapagliflozin 10 MG
  • Damanhūr, Elbehairah, Egypt
    Damanhour Teaching Hospital, General Organization for Teaching H
Oct 3, 2023

Obesity, Dapagliflozin Adverse Reaction, Weight Loss Trial (Dapagliflozin 10mg Tab)

Not yet recruiting
  • Obesity
  • +3 more
  • Dapagliflozin 10mg Tab
  • (no location specified)
Aug 14, 2023

Epilepsy Trial in Saint Louis (Empagliflozin 25 mg, Placebo)

Recruiting
  • Epilepsy
  • Empagliflozin 25 mg
  • Placebo
  • Saint Louis, Missouri
    Washington University
Aug 20, 2022

Nephrotic Syndrome, Sodium-Glucose Transporter 2 Inhibitors Trial in Cairo (Dapagliflozin 10mg Tab)

Completed
  • Nephrotic Syndrome
  • Sodium-Glucose Transporter 2 Inhibitors
  • Dapagliflozin 10mg Tab
  • Cairo, Egypt
    Ain Shams University Hospitals
Aug 31, 2023

Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan

Recruiting
  • Heart Failure
  • +2 more
  • SGLT2 inhibitor
  • Roma, RM, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCSS
Jun 28, 2023

Myocardial Ischemia Trial (Dapagliflozin 10mg Tab, Placebo)

Not yet recruiting
  • Myocardial Ischemia
  • Dapagliflozin 10mg Tab
  • Placebo
  • (no location specified)
Feb 27, 2023

Fabry Disease Trial (Dapagliflozin 10mg Tab, Placebo)

Not yet recruiting
  • Fabry Disease
  • Dapagliflozin 10mg Tab
  • Placebo
  • (no location specified)
Jan 23, 2023

Diabetes, Type 2, Cognitive Functions Confusion Trial in Chongqing (Dapagliflozin, Metformin)

Unknown status
  • Diabetes Mellitus, Type 2
  • Cognitive Functions Confusion
  • Chongqing, Chongqing, China
  • +1 more
Mar 9, 2020

Inhibitors of Type 2 Sodium Glucose Co-transporters in Diabetic

Active, not recruiting
  • Heart Failure
  • Badalona, Spain
    Germans Trias i Pujol University Hospital
Sep 6, 2021

Obesity, Type 2 Diabetes, Sodium-glucose Co-transporter-2 Inhibitor Trial (Henagliflozin, Metformin)

Not yet recruiting
  • Obesity
  • +4 more
  • (no location specified)
Sep 27, 2023

Cirrhosis, Ascites Hepatic Trial in Chandigarh (Dapagliflozin (10Mg Tab) along with standard medical therapy, Placebo of

Recruiting
  • Cirrhosis
  • Ascites Hepatic
  • Dapagliflozin (10Mg Tab) along with standard medical therapy
  • Placebo of dapaglifozin along with standard medical therapy
  • Chandigarh, India
    Dept of Hepatology, PGIMER
Sep 3, 2021

Cystinuria Trial in San Francisco (Dapagliflozin)

Recruiting
  • Cystinuria
  • San Francisco, California
    University of California, San Francisco
Oct 4, 2022

Diabetic Nephropathy Type 2 Trial (Empagliflozin 25 MG, Enalapril Maleate 20 mg)

Not yet recruiting
  • Diabetic Nephropathy Type 2
  • Empagliflozin 25 MG
  • Enalapril Maleate 20 mg
  • (no location specified)
May 9, 2022

PCO Trial in Bani Suwayf (Dapagliflozin 5 MG, Metformin Hydrochloride 1000 MG, Dapagliflozin/Metformin)

Recruiting
  • PCO
  • Dapagliflozin 5 MG
  • +2 more
  • Banī Suwayf, Beni Suef, Egypt
    Beni-suef university
Oct 26, 2022

SGLT2 Inhibition in Heart Failure

Recruiting
  • Heart Failure
  • Sodium-glucose cotransporter 2 inhibitor
  • Belfast, United Kingdom
    Belfast Health and Social Care Trust
Nov 15, 2023

SGLT-2 Inhibitors in the Treatment of Ascites

Recruiting
  • Ascites Hepatic
  • +2 more
  • SGLT2 inhibitor
  • Palermo, Italy
  • +1 more
Aug 11, 2023

Transthyretin Amyloid Cardiomyopathy Trial in New York (Empagliflozin)

Recruiting
  • Transthyretin Amyloid Cardiomyopathy
  • New York, New York
    Columbia University Irving Medical Center / NewYork-Presbyterian
Mar 15, 2022

Metabolic Syndrome, Type 2 Diabetes, Obesity Trial in Perth (Empagliflozin Oral Tablet [Jardiance], Placebo Oral Tablet)

Recruiting
  • Metabolic Syndrome
  • +2 more
  • Empagliflozin Oral Tablet [Jardiance]
  • Placebo Oral Tablet
  • Perth, Western Australia, Australia
    Royal Perth Hospital
Sep 23, 2021

Diabetic Retinopathy Trial in Cairo (Dapagliflozin 10mg Tab plus another oral hypoglycemic agent, Two oral hypoglycemic agents

Recruiting
  • Diabetic Retinopathy
  • Dapagliflozin 10mg Tab plus another oral hypoglycemic agent
  • Two oral hypoglycemic agents other than dapagliflozin
  • Cairo, Egypt
    Internal medicine and endocrinology department, Ain-shams univer
Jun 9, 2022

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • Myocardial Infarction
  • PCI
  • Naples, Italy
    Celestino Sardu
Aug 31, 2023

Anterior MI Trial in Cairo (Dapagliflozin 10mg, Glucose Tab)

Completed
  • Anterior MI
  • Dapagliflozin 10mg
  • Glucose Tab
  • Cairo, Egypt
  • +1 more
Jun 25, 2022